Phase I trial of paclitaxel, carboplatin, and topotecan with or without filgrastim (granulocyte-colony stimulating factor) in the treatment of patients with advanced, refractory cancer.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples